Skip to content

A study of the safety and efficacy of digital orthopedic technology-assisted joint arthroplasty: a prospective randomized controlled trial

A study of the safety and efficacy of digital orthopedic technology-assisted joint arthroplasty: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063223
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip and knee diseases

Interventions

Test Group:Digital Orthopaedic Technology Line Arthroplasty
Conrol group:Joint replacement with traditional instruments

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 21-80 years; 2. Able to perform surgical procedures and able to cooperate in completing follow-up visits, with good compliance; 3. Need for primary unilateral hip/knee replacement; 4. No vascular or neurological injury; 5. Voluntarily participate in this trial and sign the informed consent form in writing.

Exclusion criteria

Exclusion criteria: 1. Subjects who have undergone replacement surgery of the major joints of the ipsilateral lower extremities (hip and knee joints); 2. Clinical investigators who have participated in other research drugs or devices in the past 3 months; 3. Knee fixed flexion contractures or valgus deformities > 15°; 4. Hip/knee tumors, severe hip deformities (e.g., Crope III), hip fractures; 5. Presence of ankylosing deformities of the hip or ankle; 6. Known or suspected allergies to polyethylene, titanium, cobalt, chromium or ferrous elemental materials; 7. The subject was immunosuppressed, suffering from an autoimmune disease or immunosuppressive disorder; 8. The subject is unable to support and/or fix the prosthesis due to a disease (e.g., tumor, severe osteoporosis, or metabolic bone disease, etc.); 9. Failure to understand the requirements for participation in the study, or inability to complete the study follow-up program.

Design outcomes

Primary

MeasureTime frame
blood routin;erythrocyte sedimentation rate;C-reaction protein;Pre-operative full-length of both lower limbs;Post-operative full-length of both lower limbs;Prosthesis position;Surgery time;Intraoperative osteotomy thickness;Complications;Functional score;satisfaction;Lower limb alignment;

Countries

China

Contacts

Public ContactHuang Wei

The First Affiliated Hospital of Chongqing Medical University

17853591682@163.com+86 23 89011202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026